Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 65

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer's disease

Baglietto‐Vargas, David, Prieto, Gilberto Aleph, Limon, Agenor, Forner, Stefania, Rodriguez‐Ortiz, Carlos J., Ikemura, Kenji, Ager, Rahasson R., Medeiros, Rodrigo, Trujillo‐Estrada, Laura, Martini, Alessandra C., Kitazawa, Masashi, Davila, Jose C., Cotman, Carl W., Gutierrez, Antonia, LaFerla, Frank M. · 2018 · Aging Cell

Abstract

Summary: Alzheimer's disease (AD) is a devastating neurodegenerative disorder that impairs memory and causes cognitive and psychiatric deficits. New evidences indicate that AD is conceptualized as a disease of synaptic failure, although the molecular and cellular mechanisms underlying these defects remain to be elucidated. Determining the timing and nature of the early synaptic deficits is critical for understanding the progression of the disease and for identifying effective targets for therapeutic intervention. Using single‐synapse functional and morphological analyses, we find that AMPA signaling, which mediates fast glutamatergic synaptic transmission in the central nervous system (CNS), is compromised early in the disease course in an AD mouse model. The decline in AMPA signaling is associated with changes in actin cytoskeleton integrity, which alters the number and the structure of dendritic spines. AMPA dysfunction and spine alteration correlate with the presence of soluble but not insoluble Aβ and tau species. In particular, we demonstrate that these synaptic impairments can be mitigated by Aβ immunotherapy. Together, our data suggest that alterations in AMPA signaling and cytoskeletal processes occur early in AD. Most important, these deficits are prevented by Aβ immunotherapy, suggesting that existing therapies, if administered earlier, could confer functional benefits.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/acel.12791

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Synaptic function is early affected in 3xTg‐AD mice. (a) Confocal images stained with 6E10 (for Aβ, A1) and HT7 (for tau, A2) in 3‐month‐old 3xTg‐AD mice show no immunoreactivity at this age. (b) Confocal images stained with 6E10 (for Aβ) and HT7 (for tau) with Dapi in 7‐ to 8‐month‐old 3xTg‐AD mice show intracellular immunostain for both antibodies in the CA1 hippocampus. (c–e) Chemical long‐term potentiation (cLTP) in synaptosomes from Ntg and 3xTg‐AD mice at 3 months of age revealed no differences in the percentage of GluA1+‐Nrx1β+ events at 0, 15, 25, and 45 min after cLTP induction. (f,g) cLTP in synaptosomes from Ntg and 3xTg‐AD mice at 7–8 months of age showed significant differences in the percentage of GluA1+‐Nrx1β+ events at 45 min after cLTP induction (191.8 ± 28.9 (Ntg) vs. 107.8 ± 13.2 (3xTg‐AD), *p < 0.05, t test). The basal levels of synaptosomes were similar in both Ntg and 3xTg‐AD mice. The values represent the mean ± SEM (n = 5–7 per group). *p < 0.05. Scale bars: 100 μm (A1b, A2b, B1b, and B2b). so: stratum oriens, sp: stratum pyramidale, sr: stratum radiatum
Figure 1 Synaptic function is early affected in 3xTg‐AD mice. (a) Confocal images stained with 6E10 (for Aβ, A1) and HT7 (for tau, A2) in 3‐month‐old 3xTg‐AD mice show no immunoreactivity at this age. (b) Confocal images stained with 6E10 (for Aβ) and HT7 (for tau) with Dapi in 7‐ to 8‐month‐old 3xTg‐AD mice show intracellular immunostain for both antibodies in the CA1 hippocampus. (c–e) Chemical long‐term potentiation (cLTP) in synaptosomes from Ntg and 3xTg‐AD mice at 3 months of age revealed no differences in the percentage of GluA1+‐Nrx1β+ events at 0, 15, 25, and 45 min after cLTP induction. (f,g) cLTP in synaptosomes from Ntg and 3xTg‐AD mice at 7–8 months of age showed significant differences in the percentage of GluA1+‐Nrx1β+ events at 45 min after cLTP induction (191.8 ± 28.9 (Ntg) vs. 107.8 ± 13.2 (3xTg‐AD), *p < 0.05, t test). The basal levels of synaptosomes were similar in both Ntg and 3xTg‐AD mice. The values represent the mean ± SEM (n = 5–7 per group). *p < 0.05. Scale bars: 100 μm (A1b, A2b, B1b, and B2b). so: stratum oriens, sp: stratum pyramidale, sr: stratum radiatumCC BY · PubMed Central
Figure 2 Early functional alterations of AMPA receptors in 3xTg‐AD mice. (a) and (b) Electrophysiological recordings of synaptic‐enriched membrane preparations by microtransplantation of synaptic membranes (MSM) showed a 41% reduction in ion currents through α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptors (AMPAR) in 3xTg‐AD samples (*p < 0.05, t test, n = 5 Ntg mice, n = 4 3xTg‐AD mice). AMPARs were stimulated with 10 μM s‐AMPA coapplied with 10 μM cyclothiazide (CTZ) after preincubation in 10 μM CTZ for 3 min to remove AMPAR desensitization. (c) AMPARs from 3xTg‐AD mice showed a highly variable rise time of activation, defined as the time from the current onset to the maximum amplitude that was 4.5‐fold slower compared to Ntg (*p < 0.05, t test). The figure shows the slowest current observed in 3xTg‐AD mice. D) No difference was observed in the current–voltage relationship of steady‐state ion currents elicited with voltage ramps from −80 to +50 mV. E‐F) Immunoblot analysis of GluA1, GluA2, pGluA1, pGluA2, NR2B, and pNNR2B from hippocampal synaptosome homogenates of 7‐ to 8‐month‐old Ntg and 3xTg‐AD mice is shown as alternating lanes. Quantification of pGluA1, pGluA2, and pNR2B normalized to GluA1, GluA2, and NR2B and expressed as a % of control shows significant decreases in pGluA1 (32.22 ± 10.74, *p < 0.05, t test), pGluA2 (44.86 ± 12.76, *p < 0.05, t test), and pNR2B (37.84 ± 14.05, *p < 0.05, t test) between 3xTg‐AD mice and Ntg mice. The values represent the mean ± SEM (n = 4–7 per group). *p < 0.05
Figure 2 Early functional alterations of AMPA receptors in 3xTg‐AD mice. (a) and (b) Electrophysiological recordings of synaptic‐enriched membrane preparations by microtransplantation of synaptic membranes (MSM) showed a 41% reduction in ion currents through α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptors (AMPAR) in 3xTg‐AD samples (*p < 0.05, t test, n = 5 Ntg mice, n = 4 3xTg‐AD mice). AMPARs were stimulated with 10 μM s‐AMPA coapplied with 10 μM cyclothiazide (CTZ) after preincubation in 10 μM CTZ for 3 min to remove AMPAR desensitization. (c) AMPARs from 3xTg‐AD mice showed a highly variable rise time of activation, defined as the time from the current onset to the maximum amplitude that was 4.5‐fold slower compared to Ntg (*p < 0.05, t test). The figure shows the slowest current observed in 3xTg‐AD mice. D) No difference was observed in the current–voltage relationship of steady‐state ion currents elicited with voltage ramps from −80 to +50 mV. E‐F) Immunoblot analysis of GluA1, GluA2, pGluA1, pGluA2, NR2B, and pNNR2B from hippocampal synaptosome homogenates of 7‐ to 8‐month‐old Ntg and 3xTg‐AD mice is shown as alternating lanes. Quantification of pGluA1, pGluA2, and pNR2B normalized to GluA1, GluA2, and NR2B and expressed as a % of control shows significant decreases in pGluA1 (32.22 ± 10.74, *p < 0.05, t test), pGluA2 (44.86 ± 12.76, *p < 0.05, t test), and pNR2B (37.84 ± 14.05, *p < 0.05, t test) between 3xTg‐AD mice and Ntg mice. The values represent the mean ± SEM (n = 4–7 per group). *p < 0.05CC BY · PubMed Central
Figure 3 3xTg‐AD mice display morphological and structural dendritic spine alterations. (a,b). Immunoblot analysis of synaptophysin (Synapt) and postsynaptic density protein 95 (PSD‐95) from hippocampal synaptosome homogenates of 7‐ to 8‐month‐old Ntg and 3xTg‐AD mice is shown as alternating lanes. Quantification of PSD‐95 normalized to b‐tubulin and expressed as a % of control shows significant differences between Ntg and 3xTg‐AD mice (−22.93 ± 4.43, *p < 0.05, t test). (c,d) Light microscopic 3D reconstruction images of radiatum layer in CA1 subfield in Ntg (C1) and 3xTg‐AD (C2) mice. (d) Stereological quantification showed a significant decrease in total (34.62 ± 2.84, ***p < 0.001, t test), mushroom (36.67 ± 4.59, ***p < 0.001, t test), and thin (48.91 ± 9.47, **p < 0.01, t test) and stubby (41.47 ± 6.06, ***p < 0.001, t test) spines. In particular, immature‐like spines were increased in 3xTg‐AD mice compared to Ntg mice (80.60 ± 3.89, ****p < 0.0001, t test). (e) Electron microscopic images showed the appearance of electrodense dendritic spines in 3xTg‐AD compared to Ntg mice. (d) Spine length is increased in 3xTg‐AD compared to Ntg mice. The values represent the mean ± SEM (n = 5–7 per group). *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.001. Scale bars: 5 μm (C1 and C2) and 2 μm (E1 and E2)
Figure 3 3xTg‐AD mice display morphological and structural dendritic spine alterations. (a,b). Immunoblot analysis of synaptophysin (Synapt) and postsynaptic density protein 95 (PSD‐95) from hippocampal synaptosome homogenates of 7‐ to 8‐month‐old Ntg and 3xTg‐AD mice is shown as alternating lanes. Quantification of PSD‐95 normalized to b‐tubulin and expressed as a % of control shows significant differences between Ntg and 3xTg‐AD mice (−22.93 ± 4.43, *p < 0.05, t test). (c,d) Light microscopic 3D reconstruction images of radiatum layer in CA1 subfield in Ntg (C1) and 3xTg‐AD (C2) mice. (d) Stereological quantification showed a significant decrease in total (34.62 ± 2.84, ***p < 0.001, t test), mushroom (36.67 ± 4.59, ***p < 0.001, t test), and thin (48.91 ± 9.47, **p < 0.01, t test) and stubby (41.47 ± 6.06, ***p < 0.001, t test) spines. In particular, immature‐like spines were increased in 3xTg‐AD mice compared to Ntg mice (80.60 ± 3.89, ****p < 0.0001, t test). (e) Electron microscopic images showed the appearance of electrodense dendritic spines in 3xTg‐AD compared to Ntg mice. (d) Spine length is increased in 3xTg‐AD compared to Ntg mice. The values represent the mean ± SEM (n = 5–7 per group). *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.001. Scale bars: 5 μm (C1 and C2) and 2 μm (E1 and E2)CC BY · PubMed Central
Figure 4 Actin‐binding regulators are extensively affected in 3xTg‐AD mice. (a) NanoString technology was employed to assess RNA transcript levels of 37 cell adhesion and cytoskeleton synaptic genes (n = 4 per group). Green indicates downregulation of gene expression, and meanwhile, red indicates upregulation. The actin‐binding RNA heat‐map showed important changes in Ntg vs. 3xTg‐AD mice. (b,c) Immunoblot analysis of drebrin, spinophilin, cofilin, p‐cofilin, cortactin, p‐cortactin, and cypin from hippocampal synaptosome homogenates of 7‐ to 8‐month‐old Ntg and 3xTg‐AD mice is shown as alternating lanes. Quantification of drebrin, spinophilin, and p‐cortactin normalized to b‐tubulin and cortactin, respectively, and expressed as a % of control revealed significant decreases in drebrin (38.39 ± 8.04, *p < 0.05, t test), spinophilin (33.03 ± 11.36, *p < 0.05, t test), and p‐cortactin (43.80 ± 14.01, *p < 0.05, t test) in 3xTg‐AD mice compared to Ntg mice. (d) Immunoblot analysis of PAK and phosphor‐PAK from hippocampal synaptosome homogenates of 7‐ to 8‐month‐old Ntg and 3xTg‐AD mice is shown as alternating lanes. (e) Quantification of PAK1‐3 normalized to b‐tubulin and expressed as a % of control showed no differences between Ntg and 3xTg‐AD mice. However, phospho‐PAK1/3 (36.64 ± 6.95, *p < 0.05, t test) was significantly decreased in 3xTg‐AD compared to Ntg mice. The values represent the mean ± SEM (n = 4–7 per group). *p < 0.05, **p < 0.01, and ***p < 0.001. Scale bar: 5 μm (C1 and C2), 2 μm (E1 and E2)
Figure 4 Actin‐binding regulators are extensively affected in 3xTg‐AD mice. (a) NanoString technology was employed to assess RNA transcript levels of 37 cell adhesion and cytoskeleton synaptic genes (n = 4 per group). Green indicates downregulation of gene expression, and meanwhile, red indicates upregulation. The actin‐binding RNA heat‐map showed important changes in Ntg vs. 3xTg‐AD mice. (b,c) Immunoblot analysis of drebrin, spinophilin, cofilin, p‐cofilin, cortactin, p‐cortactin, and cypin from hippocampal synaptosome homogenates of 7‐ to 8‐month‐old Ntg and 3xTg‐AD mice is shown as alternating lanes. Quantification of drebrin, spinophilin, and p‐cortactin normalized to b‐tubulin and cortactin, respectively, and expressed as a % of control revealed significant decreases in drebrin (38.39 ± 8.04, *p < 0.05, t test), spinophilin (33.03 ± 11.36, *p < 0.05, t test), and p‐cortactin (43.80 ± 14.01, *p < 0.05, t test) in 3xTg‐AD mice compared to Ntg mice. (d) Immunoblot analysis of PAK and phosphor‐PAK from hippocampal synaptosome homogenates of 7‐ to 8‐month‐old Ntg and 3xTg‐AD mice is shown as alternating lanes. (e) Quantification of PAK1‐3 normalized to b‐tubulin and expressed as a % of control showed no differences between Ntg and 3xTg‐AD mice. However, phospho‐PAK1/3 (36.64 ± 6.95, *p < 0.05, t test) was significantly decreased in 3xTg‐AD compared to Ntg mice. The values represent the mean ± SEM (n = 4–7 per group). *p < 0.05, **p < 0.01, and ***p < 0.001. Scale bar: 5 μm (C1 and C2), 2 μm (E1 and E2)CC BY · PubMed Central
Figure 5 Aβ pathology induces synaptic loss in 3xTg‐AD mice. (a,b) Immunoblot analysis of amyloid precursor protein (APP), C‐terminal fragments (CTFs), and β‐secretase 1 (BACE1) from hippocampal synaptosome homogenates of 7‐ to 8‐month‐old Ntg and 3xTg‐AD mice is shown as alternating lanes. Quantification of APP and CTFs normalized to b‐tubulin and expressed as a % of control indicated significant increases in APP (97.97 ± 1.67, ***p < 0.001, t test) and CTFs (95.97 ± 2.48, ***p < 0.001, t test) in 3xTg‐AD mice compared to Ntg mice. (c–f) Dot blot analysis showed a significant increase in the level of Aβ‐oligomers recognized by the antibody OC (69.53 ± 18.42, ***p < 0.01, t test) in 3xTg‐AD compared to Ntg mice. (g,h) Immunoblot analysis of total tau (poly‐tau), human tau (HT7), phospho‐tau Thr181 (AT270), and Ser396/Ser404 (PHF1) from hippocampal synaptosome homogenates of 7‐ to 8‐month‐old Ntg and 3xTg‐AD mice is shown as alternating lanes. Quantification of total tau, HT7, AT270, and PHF1 normalized to b‐tubulin and expressed as a % of control showed significant increases in total tau (24.30 ± 2.09, ***p < 0.001, t test), HT7 (99.99 ± 16.25, ***p < 0.001, t test), AT270 (40.51 ± 29.50, *p < 0.05, t test), and PHF1 (49.22 ± 37.35, *p < 0.05, t test) in 3xTg‐AD mice compared to Ntg mice. (i) Immunoblot analysis of synaptic markers, actin‐binding proteins, and total GluA1 protein levels in hippocampal primary cell cultures after ADDL incubation and cLTP induction. (j) Quantification of A. The values represent the mean ± SEM (N = 8–9 per group). (k,l) Immunoblot analysis of synaptophysin, PSD‐95, drebrin, spinophilin, GluA1, and pGluA1 from hippocampal synaptosome homogenates of 7‐month‐old 3xTg‐AD‐control and 3xTg‐AD‐6E10 mice is shown as alternating lanes. Quantification synaptophysin, PSD‐95, drebrin, spinophilin, GluA1, and pGluA1 (ser845) normalized to b‐tubulin or GluA1, respectively, and expressed as a % of control revealed a significant increase in synaptophysin (44.22 ± 16.72, *p < 0.05, t test), PSD‐95 (20.87 ± 8.12, *p < 0.05, t test), drebrin (49.17 ± 14.61, *p < 0.05, t test), and pGluA1/GluA1 levels (24.38 ± 8.72, p < 0.07, t test), in 3xTg‐AD‐6E10 mice compared to 3xTg‐AD‐control mice. The values represent the mean ± SEM (N = 4–7 per group). *p < 0.05, **p < 0.01, and ***p < 0.001
Figure 5 Aβ pathology induces synaptic loss in 3xTg‐AD mice. (a,b) Immunoblot analysis of amyloid precursor protein (APP), C‐terminal fragments (CTFs), and β‐secretase 1 (BACE1) from hippocampal synaptosome homogenates of 7‐ to 8‐month‐old Ntg and 3xTg‐AD mice is shown as alternating lanes. Quantification of APP and CTFs normalized to b‐tubulin and expressed as a % of control indicated significant increases in APP (97.97 ± 1.67, ***p < 0.001, t test) and CTFs (95.97 ± 2.48, ***p < 0.001, t test) in 3xTg‐AD mice compared to Ntg mice. (c–f) Dot blot analysis showed a significant increase in the level of Aβ‐oligomers recognized by the antibody OC (69.53 ± 18.42, ***p < 0.01, t test) in 3xTg‐AD compared to Ntg mice. (g,h) Immunoblot analysis of total tau (poly‐tau), human tau (HT7), phospho‐tau Thr181 (AT270), and Ser396/Ser404 (PHF1) from hippocampal synaptosome homogenates of 7‐ to 8‐month‐old Ntg and 3xTg‐AD mice is shown as alternating lanes. Quantification of total tau, HT7, AT270, and PHF1 normalized to b‐tubulin and expressed as a % of control showed significant increases in total tau (24.30 ± 2.09, ***p < 0.001, t test), HT7 (99.99 ± 16.25, ***p < 0.001, t test), AT270 (40.51 ± 29.50, *p < 0.05, t test), and PHF1 (49.22 ± 37.35, *p < 0.05, t test) in 3xTg‐AD mice compared to Ntg mice. (i) Immunoblot analysis of synaptic markers, actin‐binding proteins, and total GluA1 protein levels in hippocampal primary cell cultures after ADDL incubation and cLTP induction. (j) Quantification of A. The values represent the mean ± SEM (N = 8–9 per group). (k,l) Immunoblot analysis of synaptophysin, PSD‐95, drebrin, spinophilin, GluA1, and pGluA1 from hippocampal synaptosome homogenates of 7‐month‐old 3xTg‐AD‐control and 3xTg‐AD‐6E10 mice is shown as alternating lanes. Quantification synaptophysin, PSD‐95, drebrin, spinophilin, GluA1, and pGluA1 (ser845) normalized to b‐tubulin or GluA1, respectively, and expressed as a % of control revealed a significant increase in synaptophysin (44.22 ± 16.72, *p < 0.05, t test), PSD‐95 (20.87 ± 8.12, *p < 0.05, t test), drebrin (49.17 ± 14.61, *p < 0.05, t test), and pGluA1/GluA1 levels (24.38 ± 8.72, p < 0.07, t test), in 3xTg‐AD‐6E10 mice compared to 3xTg‐AD‐control mice. The values represent the mean ± SEM (N = 4–7 per group). *p < 0.05, **p < 0.01, and ***p < 0.001CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

See all 65

Metadata

Authors
Baglietto‐Vargas, D., Prieto, G. A., Limon, A., Forner, S., Rodriguez‐Ortiz, C. J., Ikemura, K., Ager, R. R., Medeiros, R., Trujillo‐Estrada, L., Martini, A. C., Kitazawa, M., Davila, J. C., Cotman, C. W., Gutierrez, A., & LaFerla, F. M.
Affiliations
  • Institute for Memory Impairments and Neurological Disorders University of California Irvine California
  • Department of Psychiatry and Human Behavior University of California Irvine California
  • Department of Cell Biology, Genetic and Physiology Faculty of Sciences Biomedical Research Institute of Malaga (IBIMA) Networking Research Center on Neurodegenerative Diseases (CIBERNED) University of Malaga Malaga Spain
Venue
Aging Cell
Publisher
Wiley
Published
2018-06-06
Volume
17
Issue
4
ISSN
  • 1474-9718
  • 1474-9726
Cited by
65
References
53
Language
en
Funders
  • Alzheimer's Association (NIRG‐15‐363477, AARF‐16‐440760, MNIRGD‐15‐363229)
  • National Institutes of Health (NIH/NIA AG027544, AG00538, OD010420, AG048506, AG053740)
  • BrightFocus Foundation (A2015535S)
  • University of California (CN‐13‐613, CN‐16‐170)
  • Instituto de Salud Carlos III (PI15/00796)
  • Federación Española de Enfermedades Raras

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer's disease. https://app.cochat.ai/papers/10.1111/acel.12791
The paper
Baglietto‐Vargas, D., Prieto, G. A., Limon, A., Forner, S., Rodriguez‐Ortiz, C. J., Ikemura, K., Ager, R. R., Medeiros, R., Trujillo‐Estrada, L., Martini, A. C., Kitazawa, M., Davila, J. C., Cotman, C. W., Gutierrez, A., & LaFerla, F. M. (2018). Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer's disease. Aging Cell. https://doi.org/10.1111/acel.12791

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.